Ngā hua rapu - Charlie W. Lees

Whakamahine hua
  1. 1
    Genetics of ulcerative colitis

    Genetics of ulcerative colitis mā Alexandra Thompson, Charlie W. Lees

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities

    Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities mā Nikolas Plevris, Charlie W. Lees

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease

    Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory... mā Charlie W. Lees, Miguel Regueiro, Uma Mahadevan

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    The Hedgehog Signalling Pathway in the Gastrointestinal Tract: Implications for Development, Homeostasis, and Disease

    The Hedgehog Signalling Pathway in the Gastrointestinal Tract: Implications for Development, Homeostasis, and Disease mā Charlie W. Lees, Sarah Howie, R. Balfour Sartor, Jack Satsangi

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease

    Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease mā Charlie W. Lees, Abhishek Maan, Bhakti Hansoti, Jack Satsangi, Ian Arnott

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Systematic review: the use of thiopurines or anti‐<scp>TNF</scp> in post‐operative Crohn's disease maintenance – progress and prospects

    Systematic review: the use of thiopurines or anti‐<scp>TNF</scp> in post‐operative Crohn's disease maintenance – progress and prospects mā Gareth‐Rhys Jones, Nicholas A. Kennedy, Charlie W. Lees, Ian Arnott, Jack Satsangi

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Measurement of the Time Between Synthesis and Surface Excretion of Sebaceous Lipids in Sheep and Man

    Measurement of the Time Between Synthesis and Surface Excretion of Sebaceous Lipids in Sheep and Man mā Donald T. Downing, John S. Strauss, Petra Ramasastry, Mark F. Abel, Charlie W. Lees, Peter E. Pochi

    I whakaputaina 1975
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease

    Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease mā Nicholas A. Kennedy, Gareth‐Rhys Jones, Nikolas Plevris, Rebecca Patenden, Ian Arnott, Charlie W. Lees

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Lack of association between cervical dysplasia and IBD: A large case–control study

    Lack of association between cervical dysplasia and IBD: A large case–control study mā Charlie W. Lees, Julia Critchley, N. Chee, Thomas Beez, Ruth Gailer, Alistair Williams, Alan G. Shand, Ian Arnott, Jack Satsangi

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study

    Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study mā Alexander T. Elford, Maria Bishara, Nikolas Plevris, Beatriz Gros, Nathan Constantine‐Cooke, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad, Charlie W. Lees

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Characterization of intestinal gene expression profiles in Crohnʼs disease by genome-wide microarray analysis

    Characterization of intestinal gene expression profiles in Crohnʼs disease by genome-wide microarray analysis mā Colin Noble, Alexander R. Abbas, Charlie W. Lees, Jennine Cornelius, Karen Toy, Zora Modrušan, Hilary Clark, Ian Arnott, Ian Penman, Jack Satsangi, Lauri Diehl

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort

    Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort mā Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian Arnott, Gareth‐Rhys Jones, Charlie W. Lees, L Derikx

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis

    Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis mā Beatriz Gros, Mairi Goodall, Nikolas Plevris, Nathan Constantine‐Cooke, Alexander T. Elford, Claire O’Hare, Colin Noble, Gareth‐Rhys Jones, Ian Arnott, Charlie W. Lees

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50years

    Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50years mā Nicholas A. Kennedy, Annalie Clark, Andrew Walkden, Jeff Chang, Federica Fascì-Spurio, Martina Muscat, Brydon W. Gordon, Kathleen Kingstone, Jack Satsangi, Ian Arnott, Charlie W. Lees

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis

    The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis mā Rebecca K Grant, Gareth‐Rhys Jones, Nikolas Plevris, Ruairi Lynch, Philip Jenkinson, Charlie W. Lees, Thomas Manship, Fiona Jagger, William M Brindle, M Shivakumar, Jack Satsangi, Ian Arnott

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The use of adalimumab in the management of refractory Crohn’s disease

    The use of adalimumab in the management of refractory Crohn’s disease mā Gwo–Tzer Ho, Lesley Smith, Susan C. Aitken, H. M. Lee, Terence Ting, J. Fennell, Charlie W. Lees, K Palmér, Ian Penman, Alan G. Shand, Ian Arnott, Jack Satsangi

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing

    The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing mā Nicholas A. Kennedy, Alan W. Walker, Susan H. Berry, Sylvia H. Duncan, Freda M. Farquarson, Petra Louis, John Thomson, Jack Satsangi, Harry J. Flint, Julian Parkhill, Charlie W. Lees, Georgina L. Hold

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease

    The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease mā Nicholas A. Kennedy, Christopher A Lamb, Susan H. Berry, Alan W. Walker, John Mansfield, Miles Parkes, Rachel Simpkins, Mark Tremelling, Sarah Nutland, Julian Parkhill, Chris Probert, Georgina L. Hold, Charlie W. Lees

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology

    IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology mā Gareth‐Rhys Jones, Mathew Lyons, Nikolas Plevris, Philip Jenkinson, Cathy Bisset, Christopher Burgess, Shahida Din, James Fulforth, Paul Henderson, Gwo–Tzer Ho, Kathryn Kirkwood, Colin Noble, Alan G. Shand, David C. Wilson, Ian Arnott, Charlie W. Lees

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis

    Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis mā Laurent Peyrin–Biroulet, Perttu Arkkila, Alessandro Armuzzi, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie W. Lees, Édouard Louis, Milan Lukáš, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun, Dong‐Hyeon Kim, Sung Jeong Lee, Raja Atreya

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: